Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy

Oral cavity cancer is the most frequent malignancy of the head and neck. Unfortunately, despite educational interventions for prevention and early diagnosis, oral cancer patients are often diagnosed in advanced stages associated with poor prognosis and life expectancy. Therefore, there is an urgent...

Descripción completa

Detalles Bibliográficos
Autores: Rapado-Gonzalez, Oscar, López López, Rafael, López-Cedrun Cembranos, José Luis, Triana-Martinez, Gabriel, Muinelo Romay , Laura, Suarez-Cunqueiro, Maria Mercedes
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/15838
Acceso en línea:https://www.ncbi.nlm.nih.gov/pubmed/31861130
http://hdl.handle.net/20.500.11940/15838
Access Level:acceso abierto
Palabra clave:MicroRNAs
Humans
Saliva
Mouth Neoplasms
Prognosis
pronóstico
microARN
neoplasias de la boca
saliva
humanos
CHUAC
INIBIC
Descripción
Sumario:Oral cavity cancer is the most frequent malignancy of the head and neck. Unfortunately, despite educational interventions for prevention and early diagnosis, oral cancer patients are often diagnosed in advanced stages associated with poor prognosis and life expectancy. Therefore, there is an urgent need to find noninvasive biomarkers to improve early detection of this tumor. Liquid biopsy has emerged as a valuable tool in medical oncology which provides new horizons for improving clinical decision making. Notably, cell-free microRNAs (miRNAs), a class of short non-coding RNAs, are emerging as novel noninvasive cancer biomarkers. Here, we provide an overview of the potential clinical application of cell-free miRNAs as diagnostic, prognostic, and therapeutic biomarkers in oral cancer.